O'Dell reloaded: Do we use TNF inhibitors too early?;O'Dell reloaded: Setzen wir TNF-Inhibitoren zu schnell ein?

Zeitschrift fur Rheumatologie

Volumn 73, Issue 2, 2014, Pages 111-112

  Kruger K ^a  

^a Rheumatologisches Praxiszentrum StBonifatius ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

SHORT SURVEY; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; DRUG COMBINATION; EVIDENCE BASED MEDICINE; HUMAN; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921283216     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-013-1269-8     Document Type: Short Survey

References (9)

1. Van Vollenhoven RF, Geborek P, Forslind K et al (2012) Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial. Lancet 379:1712-1720
2. Moreland LW, O'Dell JR, Paulus HE et al (2012) A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early Aggressive Rheumatoid Arthritis. Arthritis Rheum 64:2824-2835
3. Heimans L, Wevers-de Boer KVC, Visser K et al (2013) A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study. Ann Rheum Dis (10.1136/annrheumdis-2013-203243)
4. O'Dell JR, Mikuls TR, Taylor TH et al (2013) Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. doi:10.1056/NEJMoa1303006
5. Anonym (2013) Therapiekritik: Rheumatoide Arthritis versus klassische DMARDs. arznei-telegramm 44, Nr.7, 5.7.2013, 60-61
6. Krüger K, Wollenhaupt J, Albrecht K et al (2012) S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der rheumatoiden Arthritis 2012. Z Rheumatol 71:592-603
7. Kerndokumentation der Rheumazentren 2011, nicht publizierte Daten, DRKZ 2013
8. Smolen JS, Landewé R, Breedveld FC et al (2010) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69:964-975
9. Rantalaiho V, Kautiainen H, Virta L et al (2011) Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007. Scand J Rheumatol 40:16-21